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Abstract 
Introduction: Acute viral hepatitis in children is a serious health problem throughout the world. Aims and 
Objective: To determine the profile of Hepatitis A, B, C and E as a cause of acute viral hepatitis in children in a 
tertiary care hospital of Uttarakhand, India. Material and Methods: In this retrospective study, data was collected 
from the records of paediatric patients who underwent testing for one or more of the hepatitis viruses. Serum 
samples were tested for Anti-HAV IgM and Anti-HEV IgM by Enzyme Linked Immunosorbent Assay (ELISA) and 
Hepatitis B surface antigen and Anti HCV antibodies by enhanced chemiluminiscence.  Results: Among total of 
252 patients suffering from Acute Viral Hepatitis (AVH), males predominated over females with 72.2 % vs. 27.8 %. 
Hepatitis A virus (72.6 %) was found to be the leading cause of AVH in our hospital followed by HBV (16.7 %), HEV 
(9.5 %) and the least common was HCV (1.1 %). Co-infection was seen in only 2 cases i.e one as HAV-HEV (0.4%) 
and other as HAV- HBV (0.4%). Out of all the cases of AVH, 9.5 % were suffering from Acute Hepatic Failure. 
Hepatitis A virus was found to be the most common cause of acute hepatic failure (50 %), followed by Hepatitis B 
(37.5 %) and Hepatitis E (12.5 %).  Conclusions: Hepatotropic viruses are quite prevalent in children in our country. 
Thus to control faeco-orally transmitted viruses i.e Hepatitis A and hepatitis E, awareness about healthy hygienic 
practices should be emphasized upon. Also hepatitis A vaccination can be recommended to be included in national 
immunization schedule. To prevent parenterally transmitted viruses like Hepatitis B and hepatitis C, use of sterile 
needles and syringes while tattooing, ear piercing and avoiding injections through unregistered medical 
practitioners should be done. Vaccination for hepatitis B should be routinely done. 
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Introduction  
Viral hepatitis which is affecting children’s health for 
a long time was first recognized in 1970’s. Viral 
hepatitis is caused by six distinct viruses which are 
Hepatitis A virus (HAV), Hepatitis B virus (HBV), 
Hepatitis C virus (HCV), Hepatitis D virus (HDV), 
Hepatitis E virus (HEV) and Hepatitis G virus (HGV). 
HDV is an incomplete virus and exists only with co-
infection with HBV. Each belongs to an entirely 
different family of viruses, but they have certain 
degree of shared epidemiology and the target organ 
affected is common in all i.e liver. Each of the six 
viruses has world-wide distribution. (1,2,3,4) 
HAV is a RNA virus classified under family 
Picornaviridae and it is transmitted via faeco-oral 
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route. (5) Hepatitis A virus is distributed worldwide 
and causes about 1.4 million cases each year. (6) This 
has been seen that due to improved personal and 
public hygiene along with efficient vaccination, the 
incidence of Hepatitis A has come down in developed 
countries but in developing countries such as India, 
it is still a matter of concern. HEV is also a RNA virus 
classified under family hepeviridae, transmitted by 
faeco-oral route and is prevalent in developing 
countries. (3,7) 
HBV is the only DNA virus in hepatotropic viruses 
classified in the family Hepadnaviridae genus 
Orthohepadnavirus, with eight genotypes. The virus 
is transmitted mainly via blood, body-fluid contact, 
and vertical transmission. (8) 
In the United States, recommendations for universal 
hepatitis B vaccination of infants were implemented 
in 1991 which showed greatest decline among 
children. By 2007, the incidence of acute hepatitis B 
in children <15 years had fallen to 0.02 cases per 
100,000 population. Whereas, the incidence of acute 
hepatitis B in children was approximately 13.8 cases 
and 3.03 cases per 100,000 population in 1980s and 
1990s, respectively. (9,10,11,12) 
HCV belongs to the family Flaviviridae genus 
Hepacivirus, with six major genotypes. It was first 
identified in 1989 and it is transmitted in a manner 
similar to HBV. Hepatitis C is generally 
asymptomatic, with a strong tendency (up to 80%) 
for progression to persistent and chronic infection. 
(13,14) According to a recent report, there are 
approximately 115 million people infected with HCV 
in the world, 11 million of whom are younger than 15 
years of age. (15) In the United States, antibodies to 
HCV are present in approximately 0.2 percent of 
children ages 6 to 12 and in 0.4 percent of those ages 
12 to 19. (16,17) In comparison, the frequency of 
cases that are clinically identified are far lower (5 
percent of the expected number), suggesting that 
screening and case identification of paediatric HCV 
are grossly inadequate. (18) Both HCV and HBV 
infected patients have propensity for chronic 
infection and may progress to cirrhosis and 
hepatocellular carcinoma later on. 
The general epidemiological parameters of viral 
hepatitis remain unknown or under-reported 
because there are very few studies regarding 
prevalence of hepatotropic viruses in children from 
northern India.  
 
Aims & Objectives 
To determine the prevalence of hepatotropic viruses 
among children presented to the hospital either with 
acute or chronic hepatitis or hepatic failure. 
Material and Methods 
This retrospective study was conducted in a tertiary 
care hospital in Dehradun, Uttarakhand, India. Data 
was collected from a 4 year period i.e Jan 2011-Dec 
2014 and was analyzed. Children between the age 
group of 0-18 years and suffering from acute viral 
hepatitis or acute liver failure were included in the 
study. 
Laboratory investigations: Serum samples of the 
children were analysed in the Serology laboratory for 
Anti-HAV IgM antibodies (DSI, SRL, Italy) and Anti 
HEV IgM antibodies (DSI, SRL, Italy) using 
commercially available ELISA kits. Whereas Hepatitis 
B surface antigen and Anti HCV antibodies were 
assessed by Enhanced chemiluminescence testing 
method (ECi, Vitros, USA). Furthermore, the clinical 
picture and relevant investigation details of reactive 
patients such as Serum bilirubin, Aspartate 
transaminase (AST), Alanine transaminase (ALT), 
Alkaline phosphatase (ALP), Albumin-Globulin ration 
(A:G), prothrombin time and INR were  obtained 
from patient records. 
An Acute viral hepatitis case was defined as elevated 
serum alanine aminotransferase (ALT) levels or 
Aspatate aminotransferase of atleast five-fold with 
clinical jaundice and without evidence of chronic 
liver disease. Patients who had INR > 1.5 with 
encephalopathy or INR>2 without encephalopathy 
were considered to have acute hepatic failure.20 
Statistical analysis: All data were analyzed using 
Statistical package for social sciences (SPSS) version 
IBM SPSS-22. Data is represented in the form of 
frequency and percentage. 
Results 
A total of 252 children were diagnosed as a case of 
acute viral hepatitis. Among whom, 182 (72.2%) 
children were male and 70 were female (27.8 %) thus 
giving male to female ratio as 2.6:1. Among all 
hepatotropic viruses, Hepatitis A virus was found to 
be the most common cause of AVH in our hospital 
(72.6 %) followed by Hepatitis B Virus (16.7 %), 
Hepatitis E Virus (9.1 %) and Hepatitis C Virus (1.1%). 
(Table 1) Co-infection was seen in only one case each 
i.e HAV-HEV (0.4%) and HAV- HBV (0.4%). 
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In our study, Adolescents (10-18years) were the 
predominantly affected group among children for all 
hepatotropic viruses (53.2%) followed by school 
going children (6-9years) 32.9% and pre-school 
children (12%). Very few cases were seen in toddlers 
and infants. Same pattern of positivity in correlation 
with age-group was seen in individual hepatotropic 
viruses (Table 2). 
Of all the 252 children with acute viral hepatitis, 24 
(9.5 %) were found to be suffering from acute 
hepatic failure. Out of these 24 children, 12 (50%) 
were found to have hepatitis A virus infection 
followed by 9 (37.5%) with hepatitis B virus and 3 
(12.5%) with hepatitis E virus. None of the patients 
in our study were found to be in acute hepatic failure 
due to hepatitis C virus. 
Discussion  
Few studies across the world have reported varying 
prevalence of hepatotropic viruses in children. In the 
present study, HAV (72.6 %) was identified to be the 
most common cause of acute viral hepatitis followed 
by HBV (16.7% cases), HEV (9.5% cases) and HCV (1.1 
%). Though, a study from North India also showed 
HAV being the predominant cause of acute viral 
hepatitis (44.7%) but the percentage of HAV is 
comparatively very high in our study. (19) A study 
from New Delhi in 2002 reported HEV to be the most 
prevalent hepatotropic virus (66.3 %) followed by 
HBV (8.6 %), HCV (3.1 %) and HAV (3.1 %) among 
children. (20) 
The high prevalence rate of HAV infection in children 
is due to poor hygiene, overcrowding and poor 
sanitary conditions because of abundant shedding of 
HAV in faeces. Although the improvement in sanitary 
conditions is being focussed everywhere but still 
there are many places where these practices are not 
being followed either due to illiteracy or lower 
economic status. In our study adolescents and school 
going children are the most common age group 
affected by hepatotropic viruses thus also proving 
the fact of epidemiological shift of as reported by 
Mathur et al in their study. (21)  
Safe and effective hepatitis A vaccines have been 
available since 1992, but they are not included in 
universal immunization programme in our country 
hence are significantly underused. (22) These 
vaccines are highly immunogenic and provide long-
term protection against hepatitis A. In countries of 
intermediate endemicity, WHO recommends large-
scale childhood vaccination to be considered as a 
supplement to health education and improved 
sanitation. (23, 24) 
As reported by various studies, seropositivity for 
Hepatitis B in children below 15 years ranges from 
1.3 - 12.7% in India. (25) In our study seropositivity 
for HBV is slightly higher i.e 16.7 %. The reason might 
be due to re-use of syringes while vaccination of 
children by untrained medical practitioners, sharing 
of needles while hand tattoing and ear piercing 
which are the common practices being followed in 
villages from where majority of our patients came 
from. Also, lack of Hepatitis B immunization can also 
be one of the leading causes of increased hepatitis B 
prevalence in our region. 
In our study, the HEV prevalence in children (9.1%) 
was lower than that reported by other studies (16.3-
66.3%). (26) As we all know that HEV does not have 
an effective vaccine, so it can only be prevented by 
improving sanitary conditions and socio-economic 
status. 
Seropositivity for HCV was 1.1 % in our study which 
is correlating with nearly all studies on prevalence of   
HCV except in a study by Jain et al. showing a high 
(11.98 %) prevalence of HCV among children. 19,20  
The age group most commonly affected in our study 
among children were adolescents (52.3 %) followed 
by school going children (26.1 %) and preschool 
children (9.5 %). Only 3 toddlers (7.1 %) and 2 (4.7 %) 
infants were suffering from AVH in our study (Table 
2). In contrast with, a population based study in 
Chennai, revealed a higher prevalence of Hepatitis B 
in children less than one year (12.5%). (27) 
A total of 24 children (9.5 %) were found to have 
acute hepatic failure. HAV was the major cause of 
AHF being (50 %) followed by HBV (37.5 %) and HEV 
(12.5 %). This is in contrast with some studies which 
reported HEV being the major cause for AHF. 20, (28) 
Hepatitis B being the second leading cause of AHF in 
various studies which is correlating with our study. 
(29). There were few limitations in the present study. 
The study was conducted in a tertiary care hospital 
and thus does not reflect the burden of hepatitis in 
the entire community. Population based studies 
conducted in field (for example: schools or primary 
health care unit) and also multi-centre studies may 
give more valuable data about seroprevalance rates 
of hepatotropic viruses. 
Conclusion 
To conclude, acute viral hepatitis is a significant 
problem in children. To combat and control the 
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infection, introduction of hepatitis A vaccination into 
the national immunization program seems to be 
rational for children aged >18 months. Safe sterile 
practices for injections, tattoing, ear piercing and 
vaccination is must for Hepatitis B and Hepatitis C 
prevention. Hepatitis E is less prevalent but still 
needs to be prevented by improving sanitary 
conditions and socio-economic status. 
Recommendation 
More widespread, multi-centric or field studies can 
be done to know the true burden of hepatitis in 
children. This will further help in controlling and 
combating acute viral hepatitis in children. 
Limitation of the study 
The study was conducted in a tertiary care hospital 
and thus does not reflect the true burden of hepatitis 
in the entire community. 
Relevance of the study 
The diseases caused by hepatotropic viruses can be 
controlled by improving sanitary conditions and 
socio-economic status. Hepatitis A and Hepatitis B 
are vaccine preventable diseases, so more 
awareness regarding their vaccination is needed to 
be spread in Indian society. 
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Tables 
TABLE 1 PROFILE OF VARIOUS HEPATOTROPIC VIRUSES 
Viral aetiology No. of children with AVH Prevalence 
HAV 183 (M=128, F=55) 72.6 % 
HBV 42 (M=32, F=10) 16.7 % 
HEV 24 (M=20, F=4) 9.5 % 
HCV 3 (M=2, F=1) 1.1 % 
Total 252 (M=182, F=70)  
NOTE: HAV=Hepatitis A virus; HBV=Hepatitis B virus; HCV=Hepatitis C virus; HEV= Hepatitis E virus; M=Male; F=Female 
 
TABLE 2 AGE-WISE DISTRIBUTION OF CHILDREN WITH POSITIVE SEROLOGY 
 HAV (n=183) HBV(n=42) HEV(n=24) HCV (n=3) Total children 
   <1 year (Infants) 0 2 (4.8 %) 0 0 2(0.7) 
1-3 years (Toddler) 0 3 (7.1 %) 0 0 3(1.2) 
3-5 years (Preschool children) 26 (14.2 %) 4 (9.5 %) 0 0 30(12) 
6-9 years (School children) 62 (33.9 %) 11(26.2 %) 9 (37.5 %) 1 (33.3%) 83(32.9) 
10-18 years (Adolescent) 95(51.9 %) 22 (52.4 %) 15(62.5 %) 2 (66.7%) 134(53.2) 
 
